ZBTB46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.381100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.225160E-01
Normal-vs-Stage2
8.380900E-04
Normal-vs-Stage3
1.059960E-03
Normal-vs-Stage4
5.918500E-02
Stage1-vs-Stage2
1.011830E-01
Stage1-vs-Stage3
6.599800E-02
Stage1-vs-Stage4
5.356400E-01
Stage2-vs-Stage3
2.146000E-01
Stage2-vs-Stage4
6.808800E-01
Stage3-vs-Stage4
2.146200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.739600E-03
Normal-vs-AfricanAmerican
4.678100E-03
Normal-vs-Asian
1.822330E-03
Caucasian-vs-AfricanAmerican
7.554800E-01
Caucasian-vs-Asian
1.623810E-01
AfricanAmerican-vs-Asian
4.507000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.198000E-03
Normal-vs-Female
6.856700E-03
Male-vs-Female
3.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.009000E-01
Normal-vs-Age(41-60Yrs)
1.923790E-02
Normal-vs-Age(61-80Yrs)
1.923030E-03
Normal-vs-Age(81-100Yrs)
2.078300E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.425000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.002620E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.718000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.750200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.044100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.371600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.438800E-03
Normal-vs-Daily Drinker
1.679960E-03
Normal-vs-Weekly Drinker
8.320100E-03
Normal-vs-Occasional Drinker
1.203010E-01
Normal-vs-Social Drinker
2.302000E-02
Non Drinker-vs-Daily Drinker
8.799400E-01
Non Drinker-vs-Weekly Drinker
7.655200E-01
Non Drinker-vs-Occasional Drinker
9.734400E-02
Non Drinker-vs-Social Drinker
3.090000E-01
Daily Drinker-vs-Weekly Drinker
6.537000E-01
Daily Drinker-vs-Occasional Drinker
7.999500E-02
Daily Drinker-vs-Social Drinker
2.336600E-01
Weekly Drinker-vs-Occasional Drinker
2.519600E-01
Weekly Drinker-vs-Social Drinker
5.172600E-01
Occasional Drinker-vs-Social Drinker
5.518600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.773000E-01
Normal-vs-Grade 2
8.615200E-01
Normal-vs-Grade 3
9.008000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.041000E-01
Grade 1-vs-Grade 3
9.724200E-01
Grade 1-vs-Grade 4
7.773000E-01
Grade 2-vs-Grade 3
3.614000E-01
Grade 2-vs-Grade 4
8.615200E-01
Grade 3-vs-Grade 4
9.008000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.579700E-04
Normal-vs-NonDiabetic
1.368240E-02
Diabetic-vs-NonDiabetic
2.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.513600E-02
Normal-vs-NoPancreatitis
7.163300E-03
Pancreatitis-vs-NoPancreatitis
1.863580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.672100E-02
Normal-vs-N1
4.801200E-04
N0-vs-N1
2.421200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.316170E-03
Normal-vs-TP53-NonMutant
8.576600E-03
TP53-Mutant-vs-TP53-NonMutant
6.134800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
